Issue 4, 1979

Proton magnetic resonance studies of compounds with bridgehead nitrogen. Part 35. The 5-t-butylperhydropyrido[1,2-c][1,3,7]oxadiazonine ⇌ 10,22-di-t-butylperhydrodipyrido[1,2-c:1,2-I]-1,10-dioxa-3,7,12,16-tetrazacyclodecine ⇌ 2-t-butyl-2-β-hydroxyethylperhydropyrido[1,2-c]pyrimidinium equilibrium

Abstract

The reaction between 2-(N-β-hydroxyethyl-N-β-t-butylaminoethyl)piperidine and formaldehyde gives the crystalline dimeric 10,22-di-t-butylperhydrodipyrido[1,2-c:1,2-I]-1,10-dioxa-3,7,12,16-tetrazacyclodecine. In chloroform solution this compound rapidly comes into equilibrium with 5-t-butylperhydropyrido[1,2,-c][1,3,7]oxadiazonine and the 2-t-butyl-2-β-hydroxyethylperhydropyrido[1,2-c]pyrimidinium ion. Evaporation of the chloroform followed by crystallisation of the residual oil gives the crystalline dimer.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 2, 1979, 504-506

Proton magnetic resonance studies of compounds with bridgehead nitrogen. Part 35. The 5-t-butylperhydropyrido[1,2-c][1,3,7]oxadiazonine ⇌ 10,22-di-t-butylperhydrodipyrido[1,2-c:1,2-I]-1,10-dioxa-3,7,12,16-tetrazacyclodecine ⇌ 2-t-butyl-2-β-hydroxyethylperhydropyrido[1,2-c]pyrimidinium equilibrium

T. A. Crabb and G. C. Jackson, J. Chem. Soc., Perkin Trans. 2, 1979, 504 DOI: 10.1039/P29790000504

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements